The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Preliminary results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc) for the non-L sarcoma cohort.
 
Daniel Pink
Speakers' Bureau - Blueprint Medicines (Inst); PharmaMar (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Clinigen Group (Inst); Lilly (Inst); Novartis (Inst); PharmaMar (Inst); Roche (Inst)
 
Dimosthenis Andreou
No Relationships to Disclose
 
Anne Flörcken
Travel, Accommodations, Expenses - Ipsen; PharmaMar
 
Alexander Golf
No Relationships to Disclose
 
Stephan Richter
Consulting or Advisory Role - PharmaMar
Travel, Accommodations, Expenses - Lilly; PharmaMar
 
Torsten Kessler
No Relationships to Disclose
 
Martin Kortüm
Honoraria - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Takeda
Research Funding - GlaxoSmithKline; Janssen
Travel, Accommodations, Expenses - Janssen
 
Christian Andreas Schmidt
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); PharmaMar (Inst)
Research Funding - Bristol-Myers Squibb (Inst); PharmaMar (Inst)
 
Bernd Kasper
Honoraria - PharmaMar
Research Funding - PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Eva Wardelmann
Honoraria - Bayer; Roche
Consulting or Advisory Role - Bayer; Roche
Travel, Accommodations, Expenses - Bayer; Roche
 
Jeanette Bahr
No Relationships to Disclose
 
Daniel Wilhelm Mueller
No Relationships to Disclose
 
Disorn Sookthai
Employment - Fresenius Kabi
Stock and Other Ownership Interests - Bayer
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - Institut für Klinische Krebsforschung GmbH
Consulting or Advisory Role - Bristol-Myers Squibb; Immutep; Lilly; MacroGenics; Merck Sharp & Dohme
Speakers' Bureau - AIO gGmbH; Bristol-Myers Squibb; Lilly; MCI Group
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; Eurozyto; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Hospira; Immutep; Ipsen; Lilly; Medac; MSD Sharp & Dohme; Roche; Sanofi; Vifor Pharma
 
Peter Reichardt
Honoraria - Amgen; Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; BMS; Clinigen Group; Deciphera; MSD; Roche
Research Funding - Novartis (Inst)